Abstract
The aim of this study was to evaluate the influence of chemotherapy on weight change in women having breast cancertreated at a public hospital in Goiânia-GO. This is a descriptive retrospective study analyzing the medical records of womenfrom 34 to 80 years old who met the inclusion criteria. The sample was classified as a convenience one, and met thedemand of the service. A questionnaire was used to obtain personal identification data, social-demographic data, and anthropometricdata as well as general health status. For the 30 study participants body mass index (BMI) was similar beforechemotherapy (27.45 ± 5.42 kg/m2) and after (27.53 ± 5.71 kg/m2) and placed the sample in the overweight category (BMI:25.00 to 29.99 kg/m2). Most patients were submitted to neoadjuvant treatment, being adriblastine + cyclophosphamide(AC) associated with carboplatin + paclitaxel (Taxol) the most frequent combination (80.0%). Most of the sample subjectswere overweight or obese before and after chemotherapy. Although there was weight variations due to chemotherapy protocols,no influence of chemotherapy on the nutritional status of the women in the study was identified.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
